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Abstract
Objective: To evaluate the association between endometriosis and chronic endometritis.
Methods: Endometrial specimens were obtained from 71 patients, 34 with endometriosis (endometriosis group) and 37
without endometriosis (non-endometriosis group), who underwent hysterectomy, and the specimens were immunostained
for the plasmacyte marker CD138. The rate of chronic endometritis was compared between the endometriosis group and
the non-endometriosis group. Furthermore, the 71 patients were also divided into two groups, 28 with chronic endometritis
(chronic endometritis group) and 43 without chronic endometritis (non-chronic endometritis group). Logistic regression
analysis was performed with variables including age, body mass index (BMI), gravidity and parity, and diagnoses of
leiomyoma, adenomyosis, and endometriosis on pathology to examine the independent effect of each variable on chronic
endometritis. Patients suffering from cervical invasive carcinoma, endometrial carcinoma, and endometrial polyps or treated
with gonadotropin-releasing hormone agonists, progestins, or oral contraceptives before surgery were excluded.
Results: Chronic endometritis was identified in 52.94% of the endometriosis group and 27.02% of the non-endometriosis
group (p,0.05). Logistic regression analysis revealed that endometriosis was associated with chronic endometritis.
Conclusions: This result suggests a strong association between endometriosis and chronic endometritis.
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Introduction
Chronic endometritis is a persistent inflammation of uterine
endometrium, and it is diagnosed histopathologically as plasma-
cyte infiltration within the endometrial stromal compartment
[1,2]. It is usually asymptomatic or presents only with subtle
symptoms such as abnormal uterine bleeding, pelvic pain,
dyspareunia, and leucorrhea. It has been thought not to affect
the reproductive status and ability of affected women [1].
However, recent studies have reported that chronic endometritis
is associated with infertility and recurrent abortion; it has been
identified in 12–46% of infertile patients, 30% of repeated
implantation failures after in vitro fertilization-embryo transfer,
28% of unexplained infertility, and 12% of unexplained recurrent
miscarriages [3–7]. In chronic endometritis, a number of immune
cells including plasma cells is found in the endometrium. Thus,
given the presence of abnormal immune cells in the endometrium,
chronic endometritis may affect the development and mainte-
nance of other reproductive diseases.
Endometriosis is characterized by the occurrence of endome-
trial-like tissue outside the uterus. It is a chronic disease with
symptoms such as dysmenorrhea, dyspareunia, severe chronic
pelvic pain, and infertility that interfere severely with social life and
sexual and psychological well-being, generally impairing the
quality of life of affected women [8]. Endometriosis is widely
documented as an inflammatory disease with an abnormal
immune response. Some evidence regarding the important roles
of immune cells in facilitating the development and maintenance
of endometriotic lesions has been reported [9–11]. The distribu-
tion of immune cells in the pelvic cavity has been reported to differ
between endometriosis patients and non-endometriosis patients
[12–19]. Increased activation of macrophages, along with
increased secretion and synthesis of different pro-inflammatory
mediators, cytokines, tumor necrosis factor-a, interleukins,
RANTES, platelet activating factors, fibroblast growth factors,
hepatocyte growth factor (HGF), macrophage-derived growth
factor, vascular endothelial growth factor, angiogenesis factor, and
fibronectin has been reported at ectopic sites in women with
endometriosis. Their effects may facilitate the development and
maintenance of endometriosis [13,15,16,20,21]. Changes in the
immune response within the eutopic endometrium of women with
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endometriosis have also been investigated; the distribution of
macrophages in eutopic endometrium differs between endometri-
osis patients and non-endometriosis patients [21,22]. This suggests
that endometriosis is related to abnormal immune systems in the
eutopic endometrium. Moreover, compared with eutopic endo-
metrium in non-endometriosis patients, gene expressions and
protein secretions of eutopic endometrium are known to be
modified in endometriosis patients [23–25]. Thus, the immune
system appears to be significantly modified not only at the
endometriotic site, but also within the eutopic endometrium of
women with endometriosis, affecting the viability and function of
the eutopic endometrium.
It is therefore possible to hypothesize that endometriosis may be
related to chronic endometritis. To the best of our knowledge,
there have been no reports investigating this relationship. The aim
of this study was to clarify the hypothesis by comparing the
incidence of chronic endometritis between endometriosis and non-
endometriosis patients. The present results demonstrated an
association between endometriosis and chronic endometritis.
Materials and Methods
Materials
A total of 71 untreated patients, 34 patients with endometriosis
(endometriosis group) and 37 without endometriosis (non-endo-
metriosis group), having normal menstrual cycles who underwent
hysterectomy for gynecological disease at Shiga University of
Medical Science and Takanohara Central Hospital from April
2001 to December 2012 was enrolled. This study conformed to the
Clinical Research Guidelines of Shiga University of Medical
Science and Takanohara Central Hospital, and was approved by
the research ethics committees of both establishments. Written,
informed consent to participate in this study was obtained from all
patients.
Immunohistochemistry
Paraffin-embedded endometrial specimens were used for the
study. All samples were obtained by hysterectomy. The investiga-
tors were blinded at this stage to the clinical parameters of the
specimens. The specimens were cut into 4-mm-thick sections,
placed onto a 42uC water bath, and mounted onto 3-aminopro-
pyltriethoxysaline-coated slides (FRC-05; Matsunami, Osaka,
Japan). The sections were confirmed to include a sufficient
endometrial area for the analysis. After deparaffinization and
rehydration, the slides were placed in pre-heated tris-ethylenedi-
aminetetraacetic acid (EDTA) (pH 9.0) and boiled at 98uC for
10 minutes. They were then immersed in 3% hydrogen peroxide
for 10 minutes to block endogenous peroxidase. After washing, the
sections were covered with blocking solution (PK-4002; VEC-
TASTAIN, Vector Laboratories, Burlingame, CA) for 20 minutes
to suppress non-specific antibody binding. The sections were
immunostained with anti-CD138 antibody (B-A38; Nichirei
Corp., Tokyo, Japan) for 1 hour at room temperature, followed
by washing in phosphate-buffered saline (PBS) and incubation
with horseradish peroxidase-conjugated secondary antibody
(MAX-PO; Nichirei Corp.) for 30 minutes at room temperature,
and developed with diaminobenzidine (VECTOR SK-4100;
VECTASTAIN, Vector Laboratories). The slides were counter-
stained with Mayer’s hematoxylin solution, followed by dehydra-
tion and mounting.
Analysis
In this study, a sufficient endometrial stromal area of at least two
large sections was evaluated in each patient, and the number of
immunoreactive cells was counted under a light microscope (400-
fold magnification, a high powered field; HPF). The density of
immunoreactive cells was enumerated in 10 non-overlapping
random stromal areas, and chronic endometritis was diagnosed
when one or more plasma cells were detected, since Kasius et al.
reported that the presence of only one plasma cell in the
endometrial stromal area was sufficient to diagnosis chronic
endometritis. The diagnosis of chronic endometritis was per-
formed by two separate blinded investigators.
After all procedures to diagnose chronic endometritis were
completed, the clinical parameters were disclosed. Patients treated
with gonadotropin-releasing hormone agonist, progestins, or oral
contraceptives before surgery were excluded, as were specimens
obtained during menstruation. Specimens showing cervical
invasive carcinoma, endometrial carcinoma, and endometrial
polyps were excluded. The clinical characteristics were obtained
from the documents related to the preoperative assessment. The
presence of endometriosis was identified by the operation records
and the video documentation in the cases treated by laparoscopic
surgery. The endometriosis stage was scored by the revised staging
system of the American Society of Reproductive Medicine [26].
Using the standard criteria, histological analysis revealed the
menstrual cycle date of the specimens [27].
Statistical analysis was performed using Graph Pad Prism 5
(GraphPad Software Inc., La Jolla, CA) and SPSS version 20
(SPSS Inc, Chicago, IL). Each dataset was analyzed for a normal
distribution using the Kolmogorov-Smirnov test, and Student’s t-
test or the non-parametric Mann-Whitney U test was used
depending on the distribution pattern. The statistical significance
of the difference in the rates of chronic endometritis between the
endometriosis group and the non-endometriosis group was
examined using chi-square analysis.
Significant differences were observed between the endometriosis
and the non-endometriosis groups in some aspects of the clinical
characteristics and pathological diagnoses. Therefore, the 71
patients were divided into two groups, 28 patients with chronic
endometritis (chronic endometritis group) and 43 without chronic
endometritis (non-chronic endometritis group), and stepwise
logistic regression analysis was performed to examine the
independent effect of each variable on chronic endometritis. The
analyzed variables included age, BMI, gravidity and parity, and
the pathological diagnoses of leiomyoma, adenomyosis, and
endometriosis.
After analyzing the relationship between endometriosis and
chronic endometritis, the rate of chronic endometritis was also
analyzed at each rASRM stage of endometriosis to clarify the
impact of the disease progression of endometriosis on chronic
endometritis. Furthermore, to clarify the effect of endometrioma of
the ovary and deep recto-vaginal pouch endometriosis on the
incidence of chronic endometritis, the endometriosis group was
divided into those with and without such lesions, and the rates of
chronic endometritis were calculated.
Results
Clinical parameters in the endometriosis group and the
non-endometriosis group
There were 34 patients in the endometriosis group and 37 in the
non-endometriosis group. Patients’ background clinical character-
istics are shown in Table 1. No differences were observed between
the endometriosis group and the non-endometriosis group in age,
BMI, menstrual phase (the ratio of proliferative phase to secretory
phase), menstrual duration, and frequency of dysmenorrhea. Parity
was significantly higher (p= 0.0493) in the non-endometriosis than
Chronic Endometritis in Endometriosis
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in the endometriosis group, while gravidity was not significantly
different. The endometriosis group included significantly more
specimens with adenomyosis (p,0.001) and fewer specimens
with leiomyoma (p= 0.003). The number of specimens including
carcinoma in situ (CIS) was not different. There were 9 patients
in the endometriosis group and two in the non-endometriosis
group with multiple pathological diagnoses.
Rate of chronic endometritis in the endometriosis and
non-endometriosis groups
Chronic endometritis was identified by punctate immunostain-
ing for CD138 in the stromal compartment (Figure 1A). CD138
was detected in epithelia of all sections including non-chronic
endometritis (Figure 1 B), while no immunostaining was detected
in the negative control in which anti-CD138 antibody was omitted
(Figure 1C). In the patients in whom a plasma cell was detected in
a stromal compartment, multiple plasma cells were found in other
endometrial stromal areas. Plasma cells could be found in at least
three of ten non-overlapped random fields once a plasma cell was
detected in a stromal compartment. In the patients in whom no
plasma cell was detected in 10 non-overlapped random fields of
endometrial stromal area, no plasma cells were detected in the
whole endometrial stromal area of the sections. Thus, chronic
endometritis was defined as the presence of multiple plasma cells
in 10 non-overlapped random fields of endometrial stromal area
(Figure 1D). Chronic endometritis was detected in 52.94% of the
endometriosis group and 27.02% of the non-endometriosis group;
the rate was significantly higher in the endometriosis group than in
the non-endometriosis group (p = 0.0311) (Table 2). Since there
were also significant differences in terms of adenomyosis,
leiomyoma, and parity between the endometriosis and non-
endometriosis groups (Table 1), it is possible that these factors
contributed to the result. Therefore, the effects of endometriosis,
adenomyosis, leiomyoma, and other background factors on
chronic endometritis were investigated by stepwise logistic
regression analysis.
Stepwise logistic regression analysis
The 71 patients with or without endometriosis were divided into
two groups, 28 patients with chronic endometritis (chronic
endometritis group) and 43 patients without chronic endometritis
(non-chronic endometritis group). Their background characteris-
tics and pathological results are listed in Table 3. Logistic
regression analysis was performed with variables including age,
BMI, gravidity and parity, and the diagnoses of leiomyoma,
adenomyosis, and endometriosis on pathology. No relationships
were found for age, BMI, gravidity and parity, adenomyosis,
leiomyoma, and CIS. Only the variable ‘‘endometriosis’’ was
found to be related to chronic endometritis (Table 4).
Chronic endometritis at each stage of endometriosis
The rate of chronic endometritis was analyzed at each stage of
endometriosis. Chronic endometritis was found in 40.0% of stage I
endometriosis, 50.0% of stage II, 70.0% of stage III, and 46.7% of
stage IV (Table 5). No significant difference was found between
early stages (I+II) and late stages (III+IV) (Table 6). The effects of
endometrioma of the ovary and deep recto-vaginal pouch
endometriosis on the incidence of chronic endometritis were also
evaluated. Chronic endometritis was found in 52.2% (12/23) of
endometriosis with ovarian endometrioma and 54.5% (6/11) of
endometriosis without ovarian endometrioma; no significant
difference was seen between endometriosis with and without
ovarian endometrioma. Chronic endometritis was found in 33.3%
(1/3) of endometriosis with and 54.8% (17/31) of endometriosis
without deep recto-vaginal pouch endometriosis; no significant
difference was found between them.
Discussion
Chronic endometritis is generally an asymptomatic condition
and, therefore, difficult to diagnose. Although pathological
endometrial alteration has been described as indicative of chronic
endometritis, the diagnosis ultimately relies on the presence of
plasma cells on histological examination [1,2]. To make it clear,
immunostaining for detecting plasma cells has been recom-
mended. Bayer-Garner and Korourian reported that the recog-
nition of plasma cells is difficult in endometrial tissue that includes
Table 1. Clinical characteristics and pathological diagnoses of uterus (endometriosis and non-endometriosis groups).
Endometriosis group
(n=34)
Non Endometriosis group
(n =37) P value
Age (years) 44.1563.65 43.1562.75 0.711
BMI (kg/m2) 22.0864.83 21.6063.14 0.940
Gravidity 1.9461.43 2.4361.52 0.211
Parity 1.3861.04 1.9260.95 0.049*
Menstrual average cycle (days) 27.5062.32 27.7262.58 0.664
Menstrual duration (days) 6.7361.64 6.6262.41 0.272
Dysmenorrhea (%) 58.82 (20/34) 43.24 (16/37) 0.119
Proliferative phase (%) 55.88 (19/34) 54.05 (20/37) 0.877
Secretory phase (%) 44.12 (15/34) 45.95 (17/37) 0.877
Leiomyoma (%) 67.65 (23/34) 94.59 (35/37) 0.003*
Adenomyosis (%) 47.06 (16/34) 8.11 (3/37) ,0.001*
CIS (%) 2.94 (1/34) 5.41(2/37) 0.532
*Significant difference at p,0.05.
There are 9 patients in the endometriosis group and 2 in the non endometriosis group with multiple pathological diagnoses of uterus.
doi:10.1371/journal.pone.0088354.t001
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a prominent spindle cell stromal component. They showed that
immunohistochemistry for the transmembrane heparan sulfate
proteoglycan syndecan-1 (CD138) improved the diagnostic
accuracy of chronic endometritis compared with morphological
analysis without immunohistochemistry [28]. Thus, immunostain-
ing for CD138 was used to detect plasma cells in the specimens in
the present study.
Although endometrial biopsy samples have been used for the
diagnosis of chronic endometriosis, these specimens may not be
sufficient to detect stromal plasmacyte infiltrates, since examina-
tion of the samples cannot detect the plasmacytes near and/or
within the endometrial basal layer [29]. The other concern with
using biopsy samples is that plasma cells originating in epithelium
may invade into the stromal compartment during the process of
curettage. Especially in the proliferative phase, the epithelial and
glandular area is relatively larger, and the curettage may destroy
tissue structure, causing plasma cells to lie in the stromal
compartment. Moreover, a sufficient endometrial specimen
cannot be obtained from patients with thinner endometrium.
For these reasons, specimens obtained by endometrial biopsy were
avoided in the present study. However, the use of hysterectomy
samples rather than endometrial biopsy samples was a limitation
of the study.
In the present study, the incidence of chronic endometritis was
significantly higher in the endometriosis group than in the non-
endometriosis group. Ideally, to study the relationship between
endometriosis and chronic endometritis, only the normal uterus
with myometrium and endometrium should be examined.
However, all of the specimens examined in this study included
some lesions in the myometrium, and the pathological background
was different between the endometriosis and non-endometriosis
groups. Therefore, the specimens were divided into the chronic
endometritis group and the non-chronic endometritis group, and
stepwise logistic regression analysis with the variables related to
background characteristics and pathological aspects was per-
formed to examine the independent effect of each variable on
chronic endometritis. Only the variable ‘‘endometriosis’’ was
found to be related to chronic endometritis. In other words, it was
found that only endometriosis was a significant predictor of
chronic endometritis. This result suggests a strong association
between chronic endometritis and endometriosis.
Although previous reports defined chronic endometritis as
plasmacyte infiltration within the endometrial stromal compart-
ment, no studies have defined the number of infiltrated
plasmacytes and the areas to count. Kasius et al. stated that the
presence of only one plasma cell is sufficient to diagnose chronic
endometritis [29]. In the present study, chronic endometritis was
diagnosed when there was at least one plasma cell in 10 non-
overlapping random stromal areas. In patients in whom one or
more plasma cells were detected in a stromal compartment,
multiple plasma cells were found in other endometrial stromal
areas. It was found that multiple plasma cells could be identified in
Figure 1. Immunohistochemistry for CD138. (A) Plasma cells immunostained by CD138 are detected in the stromal compartment of chronic
endometritis. (B) Plasma cells are not detected in the stromal compartment of non-chronic endometritis, although CD138 is also immunostained in
the epithelium of all sections. (C) No immunostaining is detected in the negative control in which anti-CD138 antibody has been omitted. (D) Plasma
cells can be found in at least three of ten non-overlapped random fields once a plasma cell is detected in a stromal compartment. Since chronic
endometritis does not localize focally but expands to involve the entire endometrial stroma, a number of plasma cells is detected in random
endometrial stromal compartments in chronic endometritis. Bar = 100 mm.
doi:10.1371/journal.pone.0088354.g001
Table 2. Rate of chronic endometritis in the endometriosis and non-endometriosis groups.
Endometriosis group (n =34) Non Endometriosis group (n =37) P value
Positive rate (%) 52.94 (18/34) 27.02 (10/37) 0.031*
doi:10.1371/journal.pone.0088354.t002
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at least three of ten non-overlapped random fields once a plasma
cell was detected in a stromal compartment. Since chronic
endometritis does not localize focally but expands to involve the
entire endometrial stroma, a number of plasma cells is detected in
random endometrial stromal compartments in chronic endome-
tritis. Conversely, when no plasma cells were detected in 10 non-
overlapped random fields of endometrial area, plasma cells were
not detected in the entire endometrial stromal area of the sections.
Kitaya et al. immunostained 234 specimens obtained by
hysterectomy due to benign gynecological disease and reported
that chronic endometritis was identified in 11.1% of the
endometrial specimens [30]. Compared to their result, the rate
of chronic endometritis was higher in the present study. They
reported that the number of immunoreactive cells in 10 non-
overlapping stromal areas varied from 12 to 56 in 26 chronic
endometritis cases. They excluded the patients with less than 12
immunoreactive cells. The difference in the diagnostic criteria may
explain the dissimilar results. In the present study, the stromal area
where the greatest number of plasma cells was present in each
patient was evaluated, and the greatest number in one HPF for
each patient was recorded. When comparing the number of
patients with more than 6 plasma cells in one HPF, the overall
percentage was significantly higher in the endometriosis group
than in the non-endometriosis group (29.41% vs. 5.4%,
p= 0.0101). Moreover, when the numbers of patients with over
11 plasma cells in one HPF were compared, the percentage was
significantly higher in the endometriosis group than in the non-
endometriosis group (17.65% vs. 0%, p= 0.0094). All patients with
more than 11 plasma cells in one HPF belonged to the
endometriosis group (Figure 2). Based on these results, two things
may be suggested. First, even if the criterion of chronic
endometritis is different, the prevalence of chronic endometritis
is higher in the endometriosis group. Second, the inflammation of
chronic endometritis is severe in endometriosis patients. Wood et
al. claimed that increased mucosal plasma cell counts in the
duodenal mucosa of patients with celiac disease mirrored
increased local production of immunoglobulins [31] that increase
in response to infection, chronic inflammation, and autoimmune
disease [32]. Thus, when thinking about the endometrium, it is
possible to say that accumulation of plasmacytes is related to the
severity of chronic inflammation in the endometrium, and chronic
endometritis in endometriosis may be more active, but the reason
why they accumulate in chronic endometritis still needs to be
identified.
The rate of chronic endometritis at each r-AFS stage was
analyzed (Table 5). The rates were not correlated with stage, and
deep endometriotic lesions were not related to chronic endome-
tritis. These results suggest that chronic endometritis may be an
independent complication of endometriosis or may be involved in
the pathogenesis of endometriosis, since chronic endometritis
appeared even in Stage I.
Since the uterine cavity is connected to the pelvic cavity by the
oviducts, the cells and humoral factors can pass between the
cavities. In other words, some humoral factors or substances
produced by endometriosis in the pelvic cavity can return to the
Table 3. Clinical characteristics and pathological diagnoses of uterus (chronic endometritis and non-chronic endometritis groups).
Chronic Endometritis group
(n =28)
Non Chronic Endometritis
group (n =43) P value
Age (years) 44.0063.43 44.3363.06 0.781
BMI (kg/m2) 22.9364.76 21.9463.45 0.537
Gravidity 1.9361.27 2.3761.60 0.233
Parity 1.5461.00 1.7461.05 0.384
Menstrual average cycle (days) 27.4462.39 27.7262.51 0.679
Menstrual duration (days) 6.8161.49 6.5762.41 0.135
Dysmenorrhea (%) 57.14 (16/28) 48.84 (21/43) 0.494
Diagnosis of endometriosis (%) 64.29 (18/28) 37.21 (16/43) 0.026*
Proliferative phase (%) 64.29 (18/28) 48.83 (21/43) 0.201
Secretory phase (%) 35.71 (10/28) 51.16 (22/43) 0.201
Leiomyoma (%) 75.00 (21/28) 86.04 (37/43) 0.240
Adenomyosis (%) 28.57 (8/28) 25.58 (11/43) 0.781
CIS (%) 3.57 (1/28) 4.65 (2/43) 0.658
*Significant difference at p,0.05.
There are 3 patients in the chronic endometritis group and 9 in the non chronic endometritis group with multiple pathological diagnoses of uterus.
doi:10.1371/journal.pone.0088354.t003
Table 4. Logistic regression analysis for chronic endometritis.
Variable bvalue P value Odds ratio 95% CI
Endometriosis 1.111 0.028 3.037 1.129–8.174
doi:10.1371/journal.pone.0088354.t004
Table 5. Rates of chronic endometritis in each stage of
endometriosis and comparison between early stages (I+II) and
late stages (III+IV).
r-AFS Positive rate (%)
Stage I 40.00 (2/5)
Stage II 50.00 (2/4)
Stage III 70.00 (7/10)
Stage IV 46.67 (7/15)
doi:10.1371/journal.pone.0088354.t005
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PLOS ONE | www.plosone.org 5 February 2014 | Volume 9 | Issue 2 | e88354
uterine cavity and may induce plasma cell infiltration in the
entopic endometrial stromal compartment. Conversely, the
abnormal plasma cells within the eutopic endometrium can flow
into the pelvic cavity with shed endometrium during menstruation,
and this may cause or maintain endometriosis.
The role of plasma cells in eutopic endometrium is likely to
eliminate bacteria, some organelles, and nascent neoplastic cells.
However, chronic endometritis may contribute to the promotion
of tumor development. Approximately 25% of all cancer cases is
linked to chronic inflammation caused by chronic infections (e.g.
hepatitis B and C viruses, human papilloma viruses 16 and 18, and
Helicobactor pylori), autoimmune diseases (e.g. inflammatory bowel
disease), or inflammatory conditions of uncertain origin [33,34].
Exogenous factors are able to trigger a persistent inflammatory
response. Furthermore, an inflammatory component is present in
the microenvironment of most tumors that are not epidemiolog-
ically related to inflammation [33]. Although endometriosis is not
cancer, the development of endometriosis mimics the process of
metastasis in cancer. Several studies have highlighted that immune
cell plasticity is co-opted by tumors to their own advantage. In
early phases, high production of inflammatory mediators (e.g., IL-
12,TNF, and reactive oxygen species) activates an adaptive
immune response capable of eliminating nascent neoplastic cells,
but also appears to support neoplastic transformation [35,36].
Inside the uterine cavity, chronic endometritis may contribute to
transform normal eutopic endometrium to endometriotic tissue
that can invade the pelvic cavity.
In summary, this study revealed that endometriosis is associated
with chronic endometritis. However, the cause of chronic
endometritis in endometriosis remains unclear; it may be an
infection or the endometriosis itself. Further studies are needed in
this area.
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